10/15/2020
6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2020
6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/25/2020
3:16 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2020
3:14 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5
| |
09/10/2020
3:07 PM | Brainstorm Cell Therapeutics (Issuer)
Waclawski Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2020
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Waclawski Anthony (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2020
6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2020
4:15 PM | Abbhi Sankesh (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
4:02 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B3
| |
06/26/2020
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B3
| |
|
06/01/2020
4:32 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:31 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/08/2020
11:04 AM | Brainstorm Cell Therapeutics (Subject)
Daly Joseph Patrick (Filed by)
| Form SC 13D/A
| |
05/07/2020
5:31 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/08/2020
5:01 AM | Abbhi Investments, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SC 13D
| |
04/07/2020
5:16 PM | Brainstorm Cell Therapeutics (Issuer)
Setboun David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
5:15 PM | Brainstorm Cell Therapeutics (Issuer)
Setboun David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2020
5:14 PM | Brainstorm Cell Therapeutics (Issuer)
FRENKEL JACOB A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
5:13 PM | Brainstorm Cell Therapeutics (Issuer)
FRENKEL JACOB A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2020
5:12 PM | Abbhi Sankesh (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
5:11 PM | Abbhi Sankesh (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/31/2020
6:51 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2020
8:30 PM | Abbhi Investments, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SC 13G
| |
03/06/2020
4:06 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2020
4:04 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5
| |
03/06/2020
1:35 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2020
1:32 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5
| |
02/18/2020
6:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2020
4:00 PM | Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
4:00 PM | Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
6:01 AM | Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
6:01 AM | Brainstorm Cell Therapeutics (Issuer)
Shah Preetam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2019
6:00 AM | Araya Arturo (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
4:00 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2019
6:15 AM | Brainstorm Cell Therapeutics (Subject)
Daly Joseph Patrick (Filed by)
| Form SC 13D
| |
11/14/2019
5:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/09/2019
7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2019
7:00 AM | Brainstorm Cell Therapeutics (Issuer)
Shah Preetam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
7:00 AM | Brainstorm Cell Therapeutics (Issuer)
Shah Preetam (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/02/2019
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT
| |
08/30/2019
4:02 PM | ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2019
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B1
| |
08/16/2019
4:17 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/13/2019
5:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
4:09 PM | Brainstorm Cell Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/02/2019
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B3
| |
08/02/2019
8:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2019
4:03 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2019
4:03 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2019
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2019
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5
| |
05/13/2019
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/01/2019
2:34 PM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K/A
| |
03/12/2019
5:12 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2019
4:02 PM | Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
8:00 AM | Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
3:33 PM | Brainstorm Cell Therapeutics (Issuer)
Schor Chen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
3:32 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/30/2018
4:05 PM | Brainstorm Cell Therapeutics (Issuer)
Schor Chen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:05 PM | Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:04 PM | ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:03 PM | Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:01 PM | Brainstorm Cell Therapeutics (Issuer)
TAUB MALCOLM S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:00 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2018
5:06 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2018
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A
| |
09/28/2018
4:26 PM | Brainstorm Cell Therapeutics (Filer)
| Form 424B1
| |
09/21/2018
4:17 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3/A
| |
09/04/2018
4:02 PM | Araya Arturo (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2018
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2018
7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/01/2018
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT
| |
06/29/2018
3:07 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/20/2018
5:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/08/2018
10:40 AM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2018
7:06 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B3
| |
06/07/2018
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2018
7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/26/2018
3:49 PM | Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2018
3:45 PM | Araya Arturo (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2018
9:50 AM | Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4/A
| |
03/20/2018
9:48 AM | Brainstorm Cell Therapeutics (Issuer)
Kern Ralph Dr. (Reporting)
| Form 4/A
| |
03/16/2018
5:06 AM | Almenoff June Sherie (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2018
5:07 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2018
3:50 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2018
3:30 PM | Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2018
3:30 PM | Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/04/2018
7:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
